Indo Us Biotech, a company in the Other Agricultural Products industry, reported revenue of ₹15 crore and a net loss of ₹3.67 crore for the September 2026 quarter.
Indo Us Biotech (NSE: INDOUS) closed at ₹65.46 on 20 Nov 2026, down 47.5% over the past year. Its market capitalisation is ₹131 crore and it trades at 30.2 times earnings.
Incorporated in 2004, Indo US Bio-Tech Ltd is engaged in production and processing of commercial and vegetable seeds
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.